Danaher Corporation vs ProShares UltraPro Short QQQ ETF — how do they compare? Danaher Corporation trades at $220.24 (market cap $152.87B), while ProShares UltraPro Short QQQ ETF trades at $33.02 (market cap $2.23B). The key difference: Danaher Corporation is far larger — about 68.6× ProShares UltraPro Short QQQ ETF's market cap, and Danaher Corporation pays a 0.74% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| DHR | SQQQ | |
|---|---|---|
Market Cap | $152.87B | $2.23B |
Volume | 5,228,698 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $242.05 | $89.43 |
52-Week Low | $161.91 | $31.83 |
Typical Hold Time | 69 Days | 12 Days |
Enterprise Value | $175.08B | — |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
SQQQ (ProShares UltraPro Short QQQ) trades at $33.20, up 3.49% today, reflecting bearish market sentiment toward the Nasdaq 100. Technical indicators show a predominantly bearish signal with moving averages heavily weighted toward selling pressure. The ETF is designed to deliver triple the inverse daily performance of the Nasdaq 100, making it a tactical tool for hedging or speculating on tech sector declines.
SQQQ's outlook remains tied to Nasdaq 100 volatility, with potential gains during market downturns but significant decay risk in flat or rising markets. Investors should consider the high-risk, leveraged nature of this instrument and its suitability primarily for short-term hedging strategies rather than long-term holdings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →